Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities
Net income available to common stockholders	$ 21,119	$ 24,946
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	9,086	6,663
Stock compensation expense	3,071	2,639
Other, net	244	1,619
Changes in operating assets and liabilities net of effects from acquisitions:
Trade receivables and costs in excess of billings	(7,362)	(6,950)
Inventories	(12,347)	(17,231)
Other current assets and other assets	2,492	453
Accounts payable	12,416	35,455
Accrued expenses and other non-current liabilities	(15,035)	5,587
Net cash provided by operating activities	13,684	53,181
Cash Flows from Investing Activities
Purchases of property, plant, and equipment, net	(11,431)	(4,366)
Acquisitions, net of cash acquired	(184,585)	0
Net proceeds from sale of business	352	0
Net cash used in investing activities	(195,664)	(4,366)
Cash Flows from Financing Activities
Purchase of common stock at market prices	(62,394)	(1,434)
Net cash used in financing activities	(62,394)	(1,434)
Effect of exchange rate changes on cash	8	(142)
Net (decrease) increase in cash and cash equivalents	(244,366)	47,239
Cash and cash equivalents at beginning of year	269,480	99,426
Cash and cash equivalents at end of period	$ 25,114	$ 146,665